These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 14679857)
1. [Advances in neuroimaging in schizophrenia: magnetic resonance spectroscopy]. Galińska B; Szulc A; Walecki J; Kubas B; Tarasów E Pol Merkur Lekarski; 2003 Sep; 15(87):278-80. PubMed ID: 14679857 [TBL] [Abstract][Full Text] [Related]
2. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia. Puri BK; Counsell SJ; Hamilton G Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398 [TBL] [Abstract][Full Text] [Related]
3. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488 [TBL] [Abstract][Full Text] [Related]
4. Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study. Puri BK; Counsell SJ; Hamilton G; Bustos MG; Horrobin DF; Richardson AJ; Treasaden IH Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):409-11. PubMed ID: 15041035 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla. Théberge J; Al-Semaan Y; Jensen JE; Williamson PC; Neufeld RW; Menon RS; Schaefer B; Densmore M; Drost DJ Psychiatry Res; 2004 Nov; 132(1):33-9. PubMed ID: 15546701 [TBL] [Abstract][Full Text] [Related]
6. [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations]. Wobrock T; Scherk H; Falkai P Radiologe; 2005 Feb; 45(2):124-30, 132-6. PubMed ID: 15645203 [TBL] [Abstract][Full Text] [Related]
7. Brain MRI and proton MRS findings in infants and children with respiratory chain defects. Dinopoulos A; Cecil KM; Schapiro MB; Papadimitriou A; Hadjigeorgiou GM; Wong B; deGrauw T; Egelhoff JC Neuropediatrics; 2005 Oct; 36(5):290-301. PubMed ID: 16217703 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal 4.0 Tesla (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia. Miller J; Williamson P; Jensen JE; Manchanda R; Menon R; Neufeld R; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Drost DJ Psychiatry Res; 2009 Aug; 173(2):155-7. PubMed ID: 19520552 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonace imaging study in major psychiatric disorders. Lalitanantpong D; Lalitanantpong S J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S300-8. PubMed ID: 16083207 [TBL] [Abstract][Full Text] [Related]
11. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. Reddy R; Keshavan MS Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy for studies of neurotransmission in vivo. Mason GF Psychopharmacol Bull; 2003; 37(2):26-40. PubMed ID: 14566212 [TBL] [Abstract][Full Text] [Related]
13. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia. Galińska B; Szulc A; Tarasów E; Kubas B; Dzienis W; Czernikiewicz A; Walecki J Med Sci Monit; 2009 Feb; 15(2):CR82-88. PubMed ID: 19179972 [TBL] [Abstract][Full Text] [Related]
14. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755 [TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study. Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880 [TBL] [Abstract][Full Text] [Related]
16. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings]. Szulc A Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049 [TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy in schizophrenia. Bertolino A; Weinberger DR Eur J Radiol; 1999 May; 30(2):132-41. PubMed ID: 10401594 [TBL] [Abstract][Full Text] [Related]
18. [Neuroanatomy and neurophysiology in schizophrenia]. Kasai K; Yamasue H; Araki T Seishin Shinkeigaku Zasshi; 2004; 106(7):851-66. PubMed ID: 15478627 [TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Miyaoka T; Yasukawa R; Mizuno S; Sukegawa T; Inagaki T; Horiguchi J; Seno H; Oda K; Kitagaki H J Psychiatr Res; 2005 Jan; 39(1):29-34. PubMed ID: 15504421 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Matsuzawa D; Hashimoto K Antioxid Redox Signal; 2011 Oct; 15(7):2057-65. PubMed ID: 20712400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]